Ocumetics Technology Corp.
OTCFF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$24.15M
Close$
$-0.03
109.9% downside
Current Fair Value
109.9% downsideOvervalued by 109.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $24.15 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.04 |
| Beta | 0.34 |
| Outstanding Shares | 132,296,720 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -6.95 |
|---|---|
| PEG | 11.65 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Next Earnings Call
Expected Date
November 24, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Ocumetics Technology Corp.
3 employees
CEO: Dean E. Burns
Specializing in research and product development, Ocumetics Technology Corp. engineers and manufactures a range of optical lenses. A flagship offering is the Bionic Lens, an innovative, expandable intraocular lens designed to be precisel...